JP2007532135A5 - - Google Patents

Download PDF

Info

Publication number
JP2007532135A5
JP2007532135A5 JP2007508478A JP2007508478A JP2007532135A5 JP 2007532135 A5 JP2007532135 A5 JP 2007532135A5 JP 2007508478 A JP2007508478 A JP 2007508478A JP 2007508478 A JP2007508478 A JP 2007508478A JP 2007532135 A5 JP2007532135 A5 JP 2007532135A5
Authority
JP
Japan
Prior art keywords
seq
amino acid
acid sequence
protein coupled
agonist
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007508478A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007532135A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/012447 external-priority patent/WO2005116653A2/en
Publication of JP2007532135A publication Critical patent/JP2007532135A/ja
Publication of JP2007532135A5 publication Critical patent/JP2007532135A5/ja
Pending legal-status Critical Current

Links

JP2007508478A 2004-04-13 2005-04-12 高血糖症および関連障害の処置のための、ヒトgタンパク質共役レセプターおよびそのモジュレーター Pending JP2007532135A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US56195404P 2004-04-13 2004-04-13
PCT/US2005/012447 WO2005116653A2 (en) 2004-04-13 2005-04-12 Modulators of human g protein-coupled receptors for the treatment of hyperglycemia and related disorders

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2008104153A Division JP5769361B2 (ja) 2004-04-13 2008-04-11 高血糖症および関連障害の処置のための、ヒトgタンパク質共役レセプターおよびそのモジュレーター

Publications (2)

Publication Number Publication Date
JP2007532135A JP2007532135A (ja) 2007-11-15
JP2007532135A5 true JP2007532135A5 (https=) 2008-05-29

Family

ID=35451510

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2007508478A Pending JP2007532135A (ja) 2004-04-13 2005-04-12 高血糖症および関連障害の処置のための、ヒトgタンパク質共役レセプターおよびそのモジュレーター
JP2008104153A Expired - Fee Related JP5769361B2 (ja) 2004-04-13 2008-04-11 高血糖症および関連障害の処置のための、ヒトgタンパク質共役レセプターおよびそのモジュレーター
JP2011226811A Pending JP2012050454A (ja) 2004-04-13 2011-10-14 高血糖症および関連障害の処置のための、ヒトgタンパク質共役レセプターおよびそのモジュレーター
JP2014209937A Pending JP2015064359A (ja) 2004-04-13 2014-10-14 高血糖症および関連障害の処置のための、ヒトgタンパク質共役レセプターおよびそのモジュレーター

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2008104153A Expired - Fee Related JP5769361B2 (ja) 2004-04-13 2008-04-11 高血糖症および関連障害の処置のための、ヒトgタンパク質共役レセプターおよびそのモジュレーター
JP2011226811A Pending JP2012050454A (ja) 2004-04-13 2011-10-14 高血糖症および関連障害の処置のための、ヒトgタンパク質共役レセプターおよびそのモジュレーター
JP2014209937A Pending JP2015064359A (ja) 2004-04-13 2014-10-14 高血糖症および関連障害の処置のための、ヒトgタンパク質共役レセプターおよびそのモジュレーター

Country Status (8)

Country Link
US (1) US20080306114A1 (https=)
EP (1) EP1735622A2 (https=)
JP (4) JP2007532135A (https=)
CN (1) CN101027560A (https=)
AU (1) AU2005248722A1 (https=)
CA (1) CA2564139A1 (https=)
TW (1) TW200539867A (https=)
WO (1) WO2005116653A2 (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005023253A1 (en) 2003-09-05 2005-03-17 Altana Pharma Ag Use of pde4 inhibitors for the treatment of diabetes mellitus
WO2006094942A1 (en) * 2005-03-08 2006-09-14 Nycomed Gmbh Roflumilast for the treatment of diabetes mellitus
AU2006222060B2 (en) 2005-03-08 2011-09-01 Takeda Gmbh Roflumilast for the treatment of diabetes mellitus
TW200738701A (en) 2005-07-26 2007-10-16 Du Pont Fungicidal carboxamides
WO2007100618A2 (en) * 2006-02-23 2007-09-07 Atto Bioscience Novel cell-based phosphodiesterase assays
WO2007115805A2 (en) * 2006-04-05 2007-10-18 European Molecular Biology Laboratory (Embl) Aurora kinase inhibitors
WO2008013622A2 (en) 2006-07-27 2008-01-31 E. I. Du Pont De Nemours And Company Fungicidal azocyclic amides
US9090604B2 (en) 2006-07-27 2015-07-28 E I Du Pont De Nemours And Company Fungicidal azocyclic amides
US7638541B2 (en) 2006-12-28 2009-12-29 Metabolex Inc. 5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine
JP5337711B2 (ja) 2007-01-25 2013-11-06 イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニー 殺菌性アミド
AU2008279447A1 (en) 2007-07-19 2009-01-29 Metabolex, Inc. N-azacyclic substituted pyrrole, pyrazole, imidazole, triazole and tetrazole derivatives as agonists of the RUP3 or GPR119 receptor for the treatment of diabetes and metabolic disorders
DE102007047735A1 (de) * 2007-10-05 2009-04-09 Merck Patent Gmbh Thiazolderivate
TWI428091B (zh) 2007-10-23 2014-03-01 Du Pont 殺真菌劑混合物
WO2010117090A1 (en) * 2009-04-10 2010-10-14 Banyu Pharmaceutical Co.,Ltd. Novel isoquinolinyloxymethyl heteroaryl derivatives
WO2010117084A1 (en) * 2009-04-10 2010-10-14 Banyu Pharmaceutical Co.,Ltd. Novel isoquinoline derivatives
US8410127B2 (en) 2009-10-01 2013-04-02 Metabolex, Inc. Substituted tetrazol-1-yl-phenoxymethyl-thiazol-2-yl-piperidinyl-pyrimidine salts
KR20120101019A (ko) 2009-10-30 2012-09-12 바이엘 크롭사이언스 아게 헤테로아릴피페리딘 및 -피페라진 유도체
US8653047B2 (en) * 2010-01-08 2014-02-18 Isis Pharmaceuticals, Inc. Modulation of angiopoietin-like 3 expression
AU2017305392A1 (en) 2016-08-03 2019-02-21 Cymabay Therapeutics, Inc. Oxymethylene aryl compounds for treating inflammatory gastrointestinal diseases or gastrointestinal conditions
CN113082020A (zh) * 2021-04-08 2021-07-09 徐州医科大学 一种腺苷受体激动剂的增强剂及其应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5462856A (en) * 1990-07-19 1995-10-31 Bunsen Rush Laboratories, Inc. Methods for identifying chemicals that act as agonists or antagonists for receptors and other proteins involved in signal transduction via pathways that utilize G-proteins
US6060465A (en) * 1997-02-06 2000-05-09 Miljkovic; Dusan Bile acids and their derivatives as glycoregulatory agents
JP2002000281A (ja) 2000-04-12 2002-01-08 Takeda Chem Ind Ltd 新規g蛋白質共役型レセプター蛋白質およびそのdna
US7198914B2 (en) * 2000-11-17 2007-04-03 Banyu Pharmaceutical Co., Ltd. Guanosine triphosphate (GTP)-binding protein-coupled receptor protein, BG37
JP4184697B2 (ja) * 2001-04-12 2008-11-19 武田薬品工業株式会社 スクリーニング方法
US7354726B2 (en) * 2001-04-12 2008-04-08 Takeda Pharmaceutical Company Limited Screening method
GB0230162D0 (en) * 2002-12-24 2003-02-05 Metris Therapeutics Ltd Compounds useful in inhibiting angiogenesis
US7625887B2 (en) * 2003-01-28 2009-12-01 Takeda Pharmaceutical Company Limited Receptor agonists
JP2004346059A (ja) * 2003-01-28 2004-12-09 Takeda Chem Ind Ltd 受容体作動薬

Similar Documents

Publication Publication Date Title
JP2007532135A5 (https=)
Smith Development of growth hormone secretagogues
Kukkonen et al. Functions of the orexinergic/hypocretinergic system
KR101383493B1 (ko) 정신의학적 질환 및 장애를 치료하기 위한 아밀린 및아밀린 효능제
CA2593427A1 (en) Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood glp-1 level
Olarescu et al. Normal physiology of growth hormone in adults
TW200946911A (en) Methods of using a g protein-coupled receptor to identify peptide YY (PYY) secretagogues and compounds useful in the treatment of conditions modulated by PYY
Turnbull et al. Selective antagonism of the NPY Y5 receptor does not have a major effect on feeding in rats
RU2423378C2 (ru) Композиции и способы, связанные с растворимыми сопряженными с g-белком рецепторами (sgpcr)
TW200809200A (en) Methods of using GPR119 receptor to identify compounds useful for increasing bone mass in an individual
Su et al. Activation of I2-imidazoline receptors by agmatine improved insulin sensitivity through two mechanisms in type-2 diabetic rats
Hansen et al. Effects of gastric inhibitory polypeptide, glucagon‐like peptide‐1 and glucagon‐like peptide‐1 receptor agonists on Bone Cell Metabolism
Costantini et al. GSK1614343, a novel ghrelin receptor antagonist, produces an unexpected increase of food intake and body weight in rodents and dogs
US20080182811A1 (en) Metabotropic glutamate receptor activator
JP2011516486A (ja) 骨質量疾患の診断、予防、及び治療方法
Bonaventure et al. Characterization of N-(1-Acetyl-2, 3-dihydro-1 H-indol-6-yl)-3-(3-cyano-phenyl)-N-[1-(2-cyclopentyl-ethyl)-piperidin-4yl] acrylamide (JNJ-5207787), a Small Molecule Antagonist of the Neuropeptide Y Y2 Receptor
KR20080034877A (ko) 비만 치료를 위한 약리학적 샤폐론
Ding et al. Glucose-dependent insulinotropic peptide stimulates thymidine incorporation in endothelial cells: role of endothelin-1
JP2008501632A5 (https=)
JP2019501925A (ja) Gdf11での処置は、体重増加を防止し、耐糖能を改善し、そして脂肪肝を低減する
EP2002827A2 (en) Methods and compositions for control of bone formation via modulation of sympathetic tone
TWI291555B (en) Human G protein-coupled receptor and modulators thereof for the treatment of ischemic heart disease and congestive heart failure
García et al. Thyrotropin-releasing hormone in cardiovascular pathophysiology
JP2003512040A (ja) 変異α2B−アドレノセプター・タンパク質をコードするDNA分子及びその使用
JP2005534319A5 (https=)